We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesRadNet Inc

RadNet Inc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
76.97 USD -1.11 ( 1.42%)
Last update at 2026-11-12T15:45:00Z
VOLUME
77730
Market Cap
6069.17M

Momentum Score

…

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
75.95
Low
78.25
High
52 Week Price Range
50.82
Low
85.84
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
78.08
Dividend Yield
-
Revenue TTM
2268.93M
Revenue Per Share
29.52
Gross Profit TTM
392.17M
Debt / Equity
1.71
ROE
1.50%
Net Debt
1091.64M
ROCE
3.21%
Diluted EPS TTM
-0.26

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 31.91M 44.86M 38.81M 42.97M 58.88M
Minority interest -35.70M -36.04M -25.34M 22.96M 19.59M
Net income -18.65M 2.79M 3.04M 33.61M 44.32M
Selling general administrative - - - 1265.29M 1124.02M
Gross profit 90.80M 249.12M 221.39M 165.72M 191.80M
Reconciled depreciation 211.99M 198.39M 191.19M 184.72M 170.66M
Ebit 101.82M 124.71M 103.29M 46.36M 82.55M
Ebitda 253.95M 262.55M 292.79M 243.12M 264.73M
Depreciation and amortization 152.13M 137.84M 189.49M 196.76M 182.18M
Non operating income net other - - - 47.45M 25.16M
Operating income 90.80M 104.62M 98.70M 46.36M 82.55M
Other operating expenses 1949.41M 1725.04M 1517.93M 1380.22M 1210.86M
Interest expense 69.91M 79.85M 64.48M 50.84M 48.83M
Tax provision 14.86M 6.03M 10.02M 9.36M 14.56M
Net interest income -69.91M -79.85M -63.32M -50.84M -48.83M
Non recurring - - - 2.53M 1.25M
Income tax expense 14.86M 6.03M 8.47M 9.36M 14.56M
Total revenue 2040.21M 1829.66M 1616.63M 1430.06M 1315.08M
Total operating expenses 1978.22M 144.49M 122.69M 115.88M 87.58M
Cost of revenue 1949.41M 1580.55M 1395.24M 1264.35M 1123.27M
Total other income expense net -58.90M -59.76M -59.89M -3.39M -23.68M
Net income from continuing ops 17.05M 38.84M 29.31M 33.61M 44.32M
Net income applicable to common shares - - - 10.65M 24.73M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3758.56M 3286.69M 2886.69M 2433.91M 2058.47M
Intangible assets 148.51M 81.35M 90.61M 106.23M 56.60M
Other current assets 52.00M 51.54M 47.66M 54.02M 49.21M
Total liab 2402.68M 2153.28M 2073.33M 1942.45M 1712.32M
Total stockholder equity 1089.89M 902.31M 630.70M 333.00M 228.90M
Deferred long term liab - - - 2.28M 2.13M
Other current liab 338.90M 298.66M 235.96M 23.10M 23.53M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -95.44M -76.78M -79.58M -82.62M -93.27M
Other liab - - - 32.27M 16.36M
Good will 907.66M 710.66M 679.46M 677.66M 513.82M
Other assets - - - 55.45M 53.02M
Cash 767.22M 740.02M 342.57M 127.83M 134.61M
Total current liabilities 586.76M 479.71M 437.45M 466.72M 374.78M
Current deferred revenue 7.27M 3.29M 4.65M 4.02M 10.70M
Net debt 1091.64M 988.84M 1148.55M 1385.63M 1263.18M
Short term debt 87.36M 81.31M 73.95M 70.01M 76.62M
Short long term debt 25.42M 24.69M 17.97M 12.40M 11.16M
Short long term debt total 1858.85M 1728.86M 1491.12M 1513.47M 1397.79M
Other stockholder equity 1180.43M 988.15M 722.75M 436.29M 342.59M
Property plant equipment - - - 565.96M 1068.54M
Total current assets 1032.13M 1019.25M 579.28M 367.18M 324.26M
Long term investments 130.34M 104.06M 92.71M 57.89M 42.23M
Net tangible assets - - - -450.90M -341.52M
Net receivables 212.91M 227.69M 189.05M 185.33M 140.45M
Long term debt 1064.49M 991.57M 812.07M 839.34M 743.50M
Inventory - - 0.00M - -
Accounts payable 153.23M 96.45M 122.89M 369.60M 263.94M
Noncontrolling interest in consolidated entity - - - 158.46M 117.25M
Accumulated other comprehensive income 4.88M -9.06M -12.48M -20.68M -20.42M
Common stock total equity - - - 0.01M 0.01M
Retained earnings total equity - - - -82.62M -93.27M
Non currrent assets other -1455.98M 36.84M 47.98M 55.45M 38.17M
Non current assets total 2726.44M 2267.44M 2307.42M 2066.72M 1734.21M
Capital lease obligations 768.93M 712.60M 661.08M 661.72M 643.13M
Long term debt total - - - 839.34M 743.50M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -233.07M -276.72M -1.44M -1.44M
Change to liabilities - - - 42.46M 1.43M
Total cashflows from investing activities -343.87M -233.07M -201.47M -246.95M -221.51M
Net borrowings 71.22M 165.33M -43.99M 94.25M 94.48M
Total cash from financing activities 72.21M 397.95M 195.63M 93.65M 104.67M
Change to operating activities - - - -84.44M -87.67M
Net income 46.77M 38.84M 30.34M 33.61M 44.32M
Change in cash 27.20M 397.45M 214.74M -6.77M 32.59M
Begin period cash flow 740.02M 342.57M 127.83M 134.61M 102.02M
End period cash flow 767.22M 740.02M 342.57M 127.83M 134.61M
Total cash from operating activities 298.82M 233.02M 220.86M 146.42M 149.49M
Issuance of capital stock 0.00M 218.38M 245.83M - -
Depreciation 152.13M 198.39M 189.49M 184.72M 170.66M
Other cashflows from investing activities 2.81M 0.16M 0.08M -126.06M -82.20M
Dividends paid - - - - 6.26M
Change to inventory - - - - -87.67M
Change to account receivables -9.56M -21.77M 2.65M -30.08M -5.89M
Sale purchase of stock - - - -0.60M -1.94M
Other cashflows from financing activities -4.46M 14.23M -6.20M 147.10M 855.80M
Change to netincome - - - -6.24M 42.98M
Capital expenditures 213.25M 188.07M 176.60M 249.41M 220.69M
Change receivables - - - -30.08M -5.89M
Cash flows other operating - - - -15.59M 5.97M
Cash and cash equivalents changes - - - -6.88M 32.65M
Change in working capital -9.75M -56.49M -40.27M -58.70M -92.13M
Stock based compensation 54.60M 29.83M 26.79M 23.77M 25.20M
Other non cash items 44.24M 22.45M 14.52M -50.34M 22.93M
Free cash flow 85.57M 44.95M 44.26M -103.00M -71.20M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RDNT
RadNet Inc		 -1.11
1.42%		 76.97 - 36.63 2.67 5.42 3.26 21.93
TMO
Thermo Fisher Scientific Inc		 -15.12
2.11%		 702.59 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 -1.34
0.57%		 233.97 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd		 -
-%		 24.91 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd		 -0.17
0.68%		 24.93 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

RadNet Inc

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

1510 Cotner Avenue, Los Angeles, CA, United States, 90025

310 478 7808

https://www.radnet.com

11000

Name Title Year Born
Dr. Howard G. Berger M.D. Chairman, Pres & CEO 1946
Mr. Mark D. Stolper Exec. VP & CFO 1971
Mr. Mital Patel Exec. VP of Financial Planning & Analysis and Chief Admin. Officer 1986
Mr. Norman R. Hames Pres & COO of Western Operations 1956
Mr. Stephen M. Forthuber Pres & COO of Eastern Operations 1961
Ms. Christine Nayoma Gordon Sr. VP of Operations - Northern California & Director 1963
Ms. Ruth Louisa Villiger-Wilson HR Advisor & Director 1964
Mr. Ranjan Jayanathan Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division 1956
Ms. Laura Foster BSRT, MPH, J.D. Sr. VP of Compliance & Regulatory Affairs NA
Mr. David Jeffrey Katz Exec. VP, Gen. Counsel & Corp. Sec. 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…